Latest News and Press Releases
Want to stay updated on the latest news?
-
SYDNEY, AUSTRALIA--(Marketwire - September 20, 2010) - Pharmaceutical development company, Novogen Limited (ASX: NRT) (NASDAQ: NVGN) has appointed three new Directors. Of the three...
-
OSLO, NORWAY--(Marketwire - August 30, 2010) - Bionor Pharma (OSLO: BIONOR) today announced that Henrik Lund MD Ph.D, will take over the position of CEO from Trond Syvertsen effective from 1...
-
OSLO, NORWAY and WASHINGTON, DC--(Marketwire - August 30, 2010) - Study Highlights: 25 volunteers from previously conducted Phase 2a trial were "re-vaccinated" with the vaccine after 7...
-
SYDNEY, AUSTRALIA--(Marketwire - July 23, 2010) - Novogen Limited (ASX: NRT) (NASDAQ: NVGN) is listed on the Australian Stock Exchange and has an ADR program in place in the US through the...
-
VIENNA, AUSTRIA--(Marketwire - July 22, 2010) - New data presented by researchers at the XVIII International AIDS Conference this week shows significant momentum for the emerging field of...
-
VIENNA, AUSTRIA--(Marketwire - July 22, 2010) - Researchers at Oslo University Hospital and Bionor Pharma's subsidiary, Bionor Immuno AS today presented results from a recently conducted...
-
LAS VEGAS, NV--(Marketwire - July 19, 2010) - The final of three national meetings to discuss the future of veterinary medical education concluded Friday after three days of presentations and...
-
SILVER SPRING, MD--(Marketwire - July 13, 2010) - The National Association of People with AIDS today announced that it is hosting a Community Treatment Research Forum, "Research Advances from...
-
SYDNEY, AUSTRALIA--(Marketwire - June 18, 2010) - Novogen Limited's subsidiary, Marshall Edwards, Inc. (NASDAQ: MSHL), has announced today the appointment of Mr. Thomas Zech as its CFO and Company...
-
SAN DIEGO, CA--(Marketwire - June 17, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHL), an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today...